全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1415761-37-3 | 5,8-Dibromodithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole | C10H2Br2N2S3 |
| 1415795-50-4 | Angustin A;1,8-Dihydroxy-2,3,5-trimethoxy-9H-xanthen-9-one | C16H14O7 |
| 1415795-51-5 | Angustin B;8-Hydroxy-1,2,3,5-tetramethoxy-9H-xanthen-9-one | C17H16O7 |
| 1415800-43-9 | 1,1'-[2-(Phenylamino)-1,4-phenylene]bis[1-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone];UNC 1215 | C32H43N5O2 |
| 1415824-87-1 | Tert-butyl 4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidine-1-carboxylate | C27H33N5O3 |
| 1415929-80-4 | Poly[[4,8-bis[5-(2-ethylhexyl)-2-thienyl]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl]-2,5-thiophenediyl[5,7-bis(2-ethylhexyl)-4,8-dioxo-4H,8H-benzo[1,2-c:4,5-c']dithiophene-1,3-diyl]] | |
| 1415964-02-1 | (1S,2R)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclopropanecarboxylic acid | C9H15NO4 |
| 1416013-62-1 | 2-Amino-4-bromo-3-fluorobenzoic acid | C7H5BrFNO2 |
| 1416134-47-8 | (2S,5R)-Ethyl 5-((benzyloxy)amino)piperidine-2-carboxylate | C15H22N2O3 |
| 1416134-48-9 | (2S,5R)-5-[(Phenylmethoxy)amino]-2-piperidinecarboxylic acid ethyl ester ethanedioate | C15H22N2O3.C2H2O4 |
| 1416134-49-0 | (2S,5R)-5-[(Phenylmethoxy)amino]-2-piperidinecarboxamide | C13H19N3O2 |
| 1416134-63-8 | (2S,5R)-7-Oxo-6-(phenylmethoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid ethyl ester | C16H20N2O4 |
| 1416334-69-4 | 5-(2-Amino-1-(4-morpholinophenyl)-1H-benzimidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide | C29H27FN6O4S |
| 1416354-32-9 | 1-Bromo-2,5-difluoro-3-methylbenzene | C7H5BrF2 |
| 1416366-34-1 | 2-Chloro-5-(methoxymethyl)pyrimidine | C6H7ClN2O |
| 1416372-08-1 | 2,3,4,5-Tetrahydro-7-(phenylmethoxy)-1H-1-benzazepine | C17H19NO |
| 1416372-67-2 | 5-Fluoro-2-methyl-4-pyrimidinamine | C5H6FN3 |
| 1416374-90-7 | 4-Bromo-5-chloro-2-nitrobenzoic acid methyl ester | C8H5BrClNO4 |
| 1416438-35-1 | 5-Bromo-3-iodoquinoline | C9H5BrIN |
| 1416440-61-3 | 7-Bromo-3-iodoquinoline | C9H5BrIN |
| 1416440-64-6 | Metoprolol Impurity 27;1-(4-(2-Methoxyethyl)phenoxy)-3-(oxiran-2-ylmethoxy)propan-2-OL | C15H22O5 |
| 1416450-04-8 | (alphaR)-alpha-Cyclopropylbenzenemethanamine hydrochloride | C10H13N.HCl |
| 1416549-07-9 | 1-Iodo-4-fluoro-3,5-dimethylbenzene | C8H8FI |
| 1416814-68-0 | (9-[1,1'-Biphenyl]-3-yl-9H-carbazol-3-yl)boronic acid | C24H18BNO2 |
| 1416881-52-1 | 2,4,5,6-Tetra(9H-carbazol-9-yl)isophthalonitrile;2,4,5,6-Tetra-9H-carbazol-9-yl-1,3-benzenedicarbonitrile | C56H32N6 |
| 1416881-53-2 | 2,3,5,6-Tetra-9H-carbazol-9-yl-1,4-benzenedicarbonitrile | C56H32N6 |
| 1416990-08-3 | 3-(5-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;3-(6-hydroxy-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H12N2O4 |
| 1416990-09-4 | 3-(6-hydroxy-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione;3-(5-hydroxy-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | C13H12N2O4 |
| 1416992-39-6 | GC376 sodium;Sodium (2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate | C21H30N3NaO8S |
| 1417162-36-7 | 1-(3,4-Dichlorophenyl)-3-(4-methoxyphenyl)-4-(4-morpholinyl)-1H-pyrrole-2,5-dione | C21H18Cl2N2O4 |
| 1417329-24-8 | 1-[[(2S)-5-[(Aminoiminomethyl)amino]-2-[[2-ethyl-2-[(2-methyl-1-oxopropyl)amino]-1-oxobutyl]amino]-1-oxopentyl]amino]-N-[bis(4-fluorophenyl)methyl]cyclopentanecarboxamide] | C35H49F2N7O4 |
| 1417456-04-2 | 2-Amino-6-fluoro-N-phenylbenzamide | C13H11FN2O |
| 1417567-41-9 | 1-Bromo-3-chloro-5-(trifluoromethoxy)benzene | C7H3BrClF3O |
| 1417576-00-1 | Azilsartan Impurity 6;(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-oxo-3-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-2,3-dihydro-1H-benzimidazole-4-carboxylate | C28H20N4O8 |
| 1417633-09-0 | 7-Oxa-2-azaspiro[3.5]nonane hydrochloride | C7H13NO.HCl |
| 1417788-92-1 | (3R)-3-[(1R)-1-Methylpropyl]morpholine | C8H17NO |
| 1417789-45-7 | (2S)-2-Morpholinecarboxylic acid methyl ester hydrochloride (1:1) | C6H11NO3.HCl |
| 1417789-49-1 | (1S,6R)-3,7-Diazabicyclo[4.2.0]octane-3-carboxylic acid 1,1-dimethylethyl ester | C11H20N2O2 |
| 1417789-75-3 | tert-Butyl (3S,4S)-3-(hydroxymethyl)-4-methyl-pyrrolidine-1-carboxylate | C11H21NO3 |
| 1417859-62-1 | (3S)-4-(Phenylmethyl)-3-morpholinemethanamine | C12H18N2O |
| 1417997-93-3 | (2E)-N-Hydroxy-3-(5-methoxy[1,1':4',1''-terphenyl]-2-yl)-2-propenamide | C22H19NO3 |
| 1418013-75-8 | 3-[3-(Cyclopentylthio)-5-[[[2-methyl-4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]oxy]methyl]-4H-1,2,4-triazol-4-yl]pyridine | C27H28N4O3S2 |
| 1418033-25-6 | N-[[6-(Hydroxyamino)-6-oxohexyl]oxy]-3,5-dimethyl-benzamide | C15H22N2O4 |
| 1418144-62-3 | 1-[3-Bromo-4-(hydroxymethyl)phenyl]ethanone | C9H9BrO2 |
| 1418144-66-7 | Siponimod Alcohol Impurity;(E)-1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethan-1-one O-(4-cyclohexyl-3-(trifluoromethyl)benzyl) oxime | C25H30F3NO2 |
| 1418307-17-1 | (S)-Benzyl 2-((3-chloropyrazin-2-yl)methylcarbamoyl)pyrrolidine-1-carboxylate | C18H19ClN4O3 |
| 1418307-18-2 | (2S)-2-(8-Chloroimidazo[1,5-a]pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C18H17ClN4O2 |
| 1418308-27-6 | 6-Cyano-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-1-(1-ethylpropyl)-1H-indole-4-carboxamide | C23H26N4O2 |
| 1418741-86-2 | 1,1'-(1,4-Phenylene)bis[1-[1,4'-bipiperidin]-1'-ylmethanone] | C28H42N4O2 |
| 1419075-88-9 | 4-(1,3,4-Oxadiazol-2-yl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C12H19N3O3 |